HIGHLIGHTS
- who: April and collaborators from the McGill University, Canada have published the paper: Editorial: CRISPR and beyond: Cutting-edge technologies for gene correction in therapeutic applications, in the Journal: (JOURNAL)
- what: The study shows integration frequencies around 30%-50% in T_cells and that this restores SH2D1A gene_expression and immune function in patient T_cells to levels observed in healthy controls.
- how: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
SUMMARY
Gene . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.